AI in prostate biopsies: what changed in the diagnostic room?
A study of an AI tool in prostate biopsies found a 30% reduction in report turnaround time and a 38% reduction in IHC use.
The digital sign-out display: the weak link we keep postponing
Display standards for digital sign-out in pathology are not a technical detail. This article reviews how resolution, color, calibration, and…
Roche’s acquisition of PathAI: what does it mean for AI use inside pathology laboratories?
A professional reading of Roche’s planned acquisition of PathAI, with a focus on its possible effect on diagnostic adoption, governance, and…
AISight Dx v2.20 update: when slide viewer details become part of everyday workflow quality
A practical reading of PathAI’s AISight Dx v2.20 update, focusing on the slide viewer, slide tray, archiving, and workflow management inside…
Path2Space predicts spatial gene expression from breast cancer slides
A Cell study presents Path2Space for predicting spatial gene expression from breast cancer slides, linking TME maps with survival and…
Spatial profiling reveals distinct cellular neighborhoods in asthma and COPD
A Mayo Clinic study uses spatial profiling to map distinct cellular neighborhoods in asthma and COPD, showing why a cell’s position in tissue…
From a static image to a disease trajectory: what should pathologists ask of AI-based endpoints?
A professional reading of Beyond the Slide’s argument for moving from static histologic measurements to longitudinal, interpretable…
Roche’s acquisition of PathAI: what changes inside pathology laboratories?
A pathology-focused reading of Roche’s acquisition of PathAI, valued at up to $1.05 billion, and what it may mean for digital workflows and…
PRET from HKUST: a serious test of few-data AI in digital pathology
HKUST’s PRET system uses in-context learning to analyze whole-slide images from a small number of examples, with strong results and a clear…
PathAI and A.C.Camargo collaborate in Brazil: a practical test of AI in oncology pathology
A professional reading of PathAI's collaboration with A.C.Camargo in Brazil, and what it means for pathologists working with oncology…